Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
André Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, Alec Morton & Cristina Mariano Ruas. (2018) Cost-effectiveness thresholds: methods for setting and examples from around the world. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 277-288.
Read now
Read now
Peter Hertzman, Paul Miller & Keith Tolley. (2018) An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 5-12.
Read now
Read now
Vanda Marković-Peković, Ranko Škrbić, Aleksandar Petrović, Vera Vlahović-Palčevski, Jana Mrak, Marion Bennie, Joseph Fadare, Hye-Young Kwon, Krijn Schiffers, Ilse Truter & Brian Godman. (2016) Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 609-618.
Read now
Read now
Wojciech Matusewicz, Brian Godman, Hanne Bak Pedersen, Jurij Fürst, Jolanta Gulbinovič, Asbjørn Mack, Gisbert Selke, Angela Timoney, Ewa Warmińska & Rickard E Malmström. (2015) Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe. Expert Review of Pharmacoeconomics & Outcomes Research 15:5, pages 755-758.
Read now
Read now
Brian Godman, Rickard E Malmström, Eduardo Diogene, Andy Gray, Sisira Jayathissa, Angela Timoney, Francisco Acurcio, Ali Alkan, Anna Brzezinska, Anna Bucsics, Stephen M Campbell, Jadwiga Czeczot, Winnie de Bruyn, Irene Eriksson, Faridah Aryani Md Yusof, Alexander E Finlayson, Jurij Fürst, Kristina Garuoliene, Augusto Guerra Júnior, Jolanta Gulbinovič, Saira Jan, Roberta Joppi, Marija Kalaba, Einar Magnisson, Laura McCullagh, Kaisa Miikkulainen, Gabriela Ofierska-Sujkowska, Hanne Bak Pedersen, Gisbert Selke, Catherine Sermet, Susan Spillane, Azuwana Supian, Ilse Truter, Vera Vlahović-Palčevski, Low Ee Vien, Elif H Vural, Janet Wale, Magdałene Władysiuk, Wenjie Zeng & Lars L Gustafsson. (2015) Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?. Expert Review of Clinical Pharmacology 8:1, pages 77-94.
Read now
Read now
Alessandra Ferrario, Dragana Baltezarević, Tanja Novakovic, Mark Parker & Janko Samardzic. (2014) Evidence-based decision making in healthcare in Central Eastern Europe. Expert Review of Pharmacoeconomics & Outcomes Research 14:5, pages 611-615.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Magdalena Wladysiuk, Anna Tabor & Brian Godman. (2013) ‘HTA for Crisis’: sharing experiences during the 7th EBHC Symposium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 47-49.
Read now
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now
Read now
Articles from other publishers (31)
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett & Arnold G. Vulto. (2021) The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures. Frontiers in Pharmacology 11.
Crossref
Crossref
Kyung-Bok Son. (2020) Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis. Globalization and Health 16:1.
Crossref
Crossref
Moliehi Matlala, Andries G. S. Gous, Johanna C. Meyer & Brian Godman. (2020) Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province. Frontiers in Pharmacology 11.
Crossref
Crossref
Mohamed Gad, Ahmed Salem, Wija Oortwijn, Ruaraidh Hill & Brian Godman. (2020) Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions. Frontiers in Pharmacology 11.
Crossref
Crossref
Roberto F. Iunes, Manuela Villar Uribe, Janet Bonilla Torres, Marina Morgado Garcia, Carolina Zampirolli Dias, Juliana Alvares-Teodoro, Francisco de Assis Acurcio & Augusto Afonso Guerra-Junior. (2019) Confidentiality agreements: a challenge in market regulation. International Journal for Equity in Health 18:1.
Crossref
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Crossref
Hye-Young Kwon, Hyungmin Kim & Brian Godman. (2018) Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications. Frontiers in Pharmacology 9.
Crossref
Crossref
Stephanie Ferreira Botelho, Maria Auxiliadora Parreiras Martins & Adriano Max Moreira Reis. (2018) Análise de medicamentos novos registrados no Brasil na perspectiva do Sistema Único de Saúde e da carga de doença. Ciência & Saúde Coletiva 23:1, pages 215-228.
Crossref
Crossref
Sabine Vogler. 2018. Arzneiverordnungs-Report 2018. Arzneiverordnungs-Report 2018
239
260
.
Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek, Tarik Čatić, Dávid Dankó, Maria Dimitrova, Jurij Fürst, Ieva Greičiūtė-Kuprijanov, Iris Hoxha, Arianit Jakupi, Erki Laidmäe, Olga Löblová, Ileana Mardare, Vanda Markovic-Pekovic, Dmitry Meshkov, Tanja Novakovic, Guenka Petrova, Maciej Pomorski, Dominik Tomek, Luka Voncina, Alan Haycox, Panos Kanavos, Patricia Vella Bonanno & Brian Godman. (2017) The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. PharmacoEconomics 35:12, pages 1271-1285.
Crossref
Crossref
Maria Bucek Psenkova, Martin Visnansky, Stanislava Mackovicova & Dominik Tomek. (2017) Drug Policy in Slovakia. Value in Health Regional Issues 13, pages 44-49.
Crossref
Crossref
Sabine Vogler, Valérie Paris, Alessandra Ferrario, Veronika J. Wirtz, Kees de Joncheere, Peter Schneider, Hanne Bak Pedersen, Guillaume Dedet & Zaheer-Ud-Din Babar. (2017) How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. Applied Health Economics and Health Policy 15:3, pages 307-321.
Crossref
Crossref
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Jurij Fürst, Kristina Garuolienė, Martin van der Graaff, Jolanta Gulbinovič, Alan Haycox, Jan Jones, Roberta Joppi, Ott Laius, Irene Langner, Antony P. Martin, Vanda Markovic-Pekovic, Laura McCullagh, Einar Magnusson, Ellen Nilsen, Gisbert Selke, Catherine Sermet, Steven Simoens, Robert Sauermann, Ad Schuurman, Ricardo Ramos, Vera Vlahovic-Palcevski, Corinne Zara & Brian Godman. (2016) Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways. Frontiers in Pharmacology 7.
Crossref
Crossref
Agnes Kisser, Heinz Tüchler, Judit Erdös & Claudia Wild. (2016) Factors influencing coverage decisions on medical devices: A retrospective analysis of 78 medical device appraisals for the Austrian hospital benefit catalogue 2008⿿2015. Health Policy 120:8, pages 903-912.
Crossref
Crossref
Jan R.R. LewisIan KerridgeWendy Lipworth. (2015) Coverage With Evidence Development and Managed Entry in the Funding of Personalized Medicine: Practical and Ethical Challenges for Oncology. Journal of Clinical Oncology 33:34, pages 4112-4117.
Crossref
Crossref
Humayun Riaz, Brian Godman, Shahzad Hussain, Farnaz Malik, Sidra Mahmood, Ali Shami & Sajid Bashir. (2015) Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. Journal of Pharmaceutical Health Services Research 6:2, pages 111-121.
Crossref
Crossref
Stephen M. Campbell, Brian Godman, Eduardo Diogene, Jurij Fürst, Lars L. Gustafsson, Sean MacBride-Stewart, Rickard E. Malmström, Hanne Pedersen, Gisbert Selke, Vera Vlahović-Palčevski, Menno van Woerkom, Durhane Wong-Rieger & Björn Wettermark. (2015) Quality Indicators as a Tool in Improving the Introduction of New Medicines. Basic & Clinical Pharmacology & Toxicology 116:2, pages 146-157.
Crossref
Crossref
Cornelia Jäger, Joachim Szecsenyi & Jost Steinhäuser. (2015) Design and Delivery of a Tailored Intervention to Implement Recommendations for Multimorbid Patients Receiving Polypharmacy into Primary Care Practices. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Elisangela da Costa Lima-Dellamora, Rosângela Caetano, Lars L. Gustafsson, Brian B. Godman, Ken Patterson & Claudia Garcia Serpa Osorio-de-Castro. (2014) An Analytical Framework for Assessing Drug and Therapeutics Committee Structure and Work Processes in Tertiary Brazilian Hospitals. Basic & Clinical Pharmacology & Toxicology 115:3, pages 268-276.
Crossref
Crossref
Wenjie Zeng, Junjie Zhen, Mengying Feng, Stephen M Campbell, Alexander E Finlayson & Brian Godman. (2014) Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction. Journal of Comparative Effectiveness Research 3:4, pages 371-386.
Crossref
Crossref
Ana Luísa Caires de Souza, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnior, Renata Cristina Rezende Macedo do Nascimento, Brian Godman & Leonardo Maurício Diniz. (2014) Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review. Applied Health Economics and Health Policy 12:1, pages 19-32.
Crossref
Crossref
Brian Godman, Alexander E Finlayson, Parneet K Cheema, Eva Zebedin-Brandl, Inaki Gutiérrez-Ibarluzea, Jan Jones, Rickard E Malmström, Elina Asola, Christoph Baumgärtel, Marion Bennie, Iain Bishop, Anna Bucsics, Stephen Campbell, Eduardo Diogene, Alessandra Ferrario, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Katharine Harris, Alan Haycox, Harald Herholz, Krystyna Hviding, Saira Jan, Marija Kalaba, Christina Kvalheim, Ott Laius, Sven-Ake Lööv, Kamila Malinowska, Andrew Martin, Laura McCullagh, Fredrik Nilsson, Ken Paterson, Ulrich Schwabe, Gisbert Selke, Catherine Sermet, Steven Simoens, Dominik Tomek, Vera Vlahovic-Palcevski, Luka Voncina, Magdalena Wladysiuk, Menno van Woerkom, Durhane Wong-Rieger, Corrine Zara, Raghib Ali & Lars L Gustafsson. (2013) Personalizing health care: feasibility and future implications. BMC Medicine 11:1.
Crossref
Crossref
Steven G. Morgan, Paige A. Thomson, Jamie R. Daw & Melissa K. Friesen. (2013) Canadian policy makers’ views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers. Health Policy 112:3, pages 248-254.
Crossref
Crossref
Pieter Dylst, Arnold Vulto, Brian Godman & Steven Simoens. (2013) Generic Medicines: Solutions for a Sustainable Drug Market?. Applied Health Economics and Health Policy 11:5, pages 437-443.
Crossref
Crossref
B. Godman, B. Wettermark, J. Miranda, M. Bennie, A. Martin & R. E. Malmström. (2013) Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries. International Journal of Clinical Practice 67:9, pages 853-862.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref
Crossref
Sylvain Pichetti, Catherine Sermet, Brian Godman, Stephen M. Campbell & Lars L. Gustafsson. (2013) Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France. Applied Health Economics and Health Policy 11:3, pages 205-218.
Crossref
Crossref
Linda Björkhem-Bergman, Eva Andersén-Karlsson, Richard Laing, Eduardo Diogene, Oyvind Melien, Malena Jirlow, Rickard E. Malmström, Sabine Vogler, Brian Godman & Lars L Gustafsson. (2013) Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. European Journal of Clinical Pharmacology 69:S1, pages 73-78.
Crossref
Crossref
Brian Godman & Lars L. Gustafsson. (2013) A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy 11:1, pages 79-82.
Crossref
Crossref
Marija KalabaBrian Godman, Aleksandar Vuksanović, Marion Bennie & Richard E Malmström. (2012) Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?. Journal of Comparative Effectiveness Research 1:6, pages 539-549.
Crossref
Crossref